ENG and preeclampsia: Circulating levels of soluble endoglin are elevated in preeclampsia, hypercholesterolemia, diabetes, atherosclerosis, severe pulmonary arterial hypertension, acute myocardial infarction and some types of solid cancers [27–29, 52–54].